AAAAAA

   
Results: 1-16 |
Results: 16
P63, A P53 HOMOLOG AT 3Q27-29, ENCODES MULTIPLE PRODUCTS WITH TRANSACTIVATING, DEATH-INDUCING, AND DOMINANT-NEGATIVE ACTIVITIES
Authors: YANG AN KAGHAD M WANG YM GILLETT E FLEMING MD DOTSCH V ANDREWS NC CAPUT D MCKEON F
Citation: An. Yang et al., P63, A P53 HOMOLOG AT 3Q27-29, ENCODES MULTIPLE PRODUCTS WITH TRANSACTIVATING, DEATH-INDUCING, AND DOMINANT-NEGATIVE ACTIVITIES, MOLECULAR CELL, 2(3), 1998, pp. 305-316
HEPATIC IRON OVERLOAD IN THE AGE OF HEREDITARY HEMOCHROMATOSIS MUTATION ANALYSIS
Authors: FLEMING MD
Citation: Md. Fleming, HEPATIC IRON OVERLOAD IN THE AGE OF HEREDITARY HEMOCHROMATOSIS MUTATION ANALYSIS, AJCP. American journal of clinical pathology, 109(5), 1998, pp. 505-507
ABSENCE OF DENDRITIC RETICULUM-CELL STAINING IS HELPFUL FOR DISTINGUISHING T-CELL-RICH B-CELL LYMPHOMA FROM LYMPHOCYTE PREDOMINANCE HODGKINS-DISEASE
Authors: FLEMING MD SHAHSAFAEI A DORFMAN DM
Citation: Md. Fleming et al., ABSENCE OF DENDRITIC RETICULUM-CELL STAINING IS HELPFUL FOR DISTINGUISHING T-CELL-RICH B-CELL LYMPHOMA FROM LYMPHOCYTE PREDOMINANCE HODGKINS-DISEASE, Applied immunohistochemistry, 6(1), 1998, pp. 16-22
SPLENIC PATHOLOGY IN MYELODYSPLASIA - A REPORT OF 13 CASES WITH CLINICAL CORRELATION
Authors: KRAUS MD BARTLETT NL FLEMING MD DORFMAN DM
Citation: Md. Kraus et al., SPLENIC PATHOLOGY IN MYELODYSPLASIA - A REPORT OF 13 CASES WITH CLINICAL CORRELATION, The American journal of surgical pathology, 22(10), 1998, pp. 1255-1266
NRAMP2 IS MUTATED IN THE ANEMIC BELGRADE (B) RAT - EVIDENCE OF A ROLEFOR NRAMP2 IN ENDOSOMAL IRON TRANSPORT
Authors: FLEMING MD ROMANO MA SU MA GARRICK LM GARRICK MD ANDREWS NC
Citation: Md. Fleming et al., NRAMP2 IS MUTATED IN THE ANEMIC BELGRADE (B) RAT - EVIDENCE OF A ROLEFOR NRAMP2 IN ENDOSOMAL IRON TRANSPORT, Proceedings of the National Academy of Sciences of the United Statesof America, 95(3), 1998, pp. 1148-1153
THE G185R MUTATION DISRUPTS FUNCTIONS OF THE IRON TRANSPORTER NRAMP2
Authors: SU MA TRENOR CC FLEMING JC FLEMING MD ANDREWS NC
Citation: Ma. Su et al., THE G185R MUTATION DISRUPTS FUNCTIONS OF THE IRON TRANSPORTER NRAMP2, Blood, 92(6), 1998, pp. 2157-2163
MICROCYTIC ANEMIA MICE HAVE A MUTATION IN NRAMP2, A CANDIDATE IRON TRANSPORTER GENE
Authors: FLEMING MD TRENOR CC SU MA FOERNZLER D BEIER DR DIETRICH WF ANDREWS NC
Citation: Md. Fleming et al., MICROCYTIC ANEMIA MICE HAVE A MUTATION IN NRAMP2, A CANDIDATE IRON TRANSPORTER GENE, Nature genetics, 16(4), 1997, pp. 383-386
ANGIOSARCOMA
Authors: VONDERHEIDE RH FLEMING MD CARTER G SINGER S DEMETRI G
Citation: Rh. Vonderheide et al., ANGIOSARCOMA, Journal of clinical oncology, 15(4), 1997, pp. 1708-1709
THE IRON TRANSPORTER NRAMP2 IS MUTATED IN THE ANEMIC BELGRADE(B) RAT
Authors: FLEMING MD ROMANO MA GARRICK LM GARRICK MD ANDREWS NC
Citation: Md. Fleming et al., THE IRON TRANSPORTER NRAMP2 IS MUTATED IN THE ANEMIC BELGRADE(B) RAT, Blood, 90(10), 1997, pp. 2675-2675
NRAMP2 IS AN IRON TRANSPORTER AND IS DEFECTIVE IN MICROCYTIC (MK) MICE
Authors: SU M TRENOR CC FLEMING JC FLEMING MD ANDREWS NC
Citation: M. Su et al., NRAMP2 IS AN IRON TRANSPORTER AND IS DEFECTIVE IN MICROCYTIC (MK) MICE, Blood, 90(10), 1997, pp. 2676-2676
LONG-TERM RESULTS OF BREAST-CONSERVATION THERAPY FOR BREAST-CANCER
Authors: NEFF PT BEAR HD PIERCE CV GRIMES MM FLEMING MD NEIFELD JP ARTHUR D HORSLEY JS LAWRENCE W KORNSTEIN MJ
Citation: Pt. Neff et al., LONG-TERM RESULTS OF BREAST-CONSERVATION THERAPY FOR BREAST-CANCER, Annals of surgery, 223(6), 1996, pp. 709-716
ADOPTIVE TRANSFER OF BRYOSTATIN-ACTIVATED TUMOR-SENSITIZED LYMPHOCYTES PREVENTS OR DESTROYS TUMOR-METASTASES WITHOUT EXPANSION IN-VITRO
Authors: FLEMING MD BEAR HD LIPSHY K KOSTUCHENKO PJ PORTOCARERO D MCFADDEN AWJ BARRETT SK
Citation: Md. Fleming et al., ADOPTIVE TRANSFER OF BRYOSTATIN-ACTIVATED TUMOR-SENSITIZED LYMPHOCYTES PREVENTS OR DESTROYS TUMOR-METASTASES WITHOUT EXPANSION IN-VITRO, Journal of immunotherapy with emphasis on tumor immunology, 18(3), 1995, pp. 147-155
PRINCIPLES OF MANAGEMENT OF BASAL AND SQUAMOUS-CELL CARCINOMA OF THE SKIN
Authors: FLEMING ID AMONETTE R MONAGHAN T FLEMING MD
Citation: Id. Fleming et al., PRINCIPLES OF MANAGEMENT OF BASAL AND SQUAMOUS-CELL CARCINOMA OF THE SKIN, Cancer, 75(2), 1995, pp. 699-704
ABILITY OF LOW-DOSE CYCLOPHOSPHAMIDE TO OVERCOME METASTASIS-INDUCED IMMUNOSUPPRESSION
Authors: TUTTLE TM FLEMING MD HOGG PS INGE TH BEAR HD
Citation: Tm. Tuttle et al., ABILITY OF LOW-DOSE CYCLOPHOSPHAMIDE TO OVERCOME METASTASIS-INDUCED IMMUNOSUPPRESSION, Annals of surgical oncology, 1(1), 1994, pp. 53-58
PRECURSOR FREQUENCY-ANALYSIS OF BRYOSTATIN ACTIVATED LYMPHOCYTES
Authors: FLEMING MD BARRETT SK BEAR HD
Citation: Md. Fleming et al., PRECURSOR FREQUENCY-ANALYSIS OF BRYOSTATIN ACTIVATED LYMPHOCYTES, The Journal of surgical research, 57(1), 1994, pp. 74-79
BREAST-CANCER IN ELDERLY WOMEN
Authors: FLEMING ID FLEMING MD
Citation: Id. Fleming et Md. Fleming, BREAST-CANCER IN ELDERLY WOMEN, Cancer, 74(7), 1994, pp. 2160-2164
Risultati: 1-16 |